[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336248-105":3,"doc-detail-336248-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","anticancer-potency-of-egyptian-venom-snakes-on-mcf-7-and-hepg2-carcinoma-cells","Anticancer potency of Egyptian venom snakes on MCF-7 and HepG2 carcinoma cells","","Breast and hepatic cancers represent leading sources of human suffering worldwide, motivating the search for effective anticancer agents. Snake venoms have been reported as therapeutic candidates. This study evaluates the anticancer potency of Egyptian snake venoms against two in vitro tumor cell lines: breast cancer (MCF-7) and hepatocarcinoma (HepG2). Venoms show higher potency on MCF-7, with MCF-7 inhibition percentages up to 99.02% and IC50 values in the low µg/ml range. On HepG2, IC50s vary widely. Biomarker analyses assess apoptotic-related effects including LDH activity changes and modulation of GSH and MDA, alongside DNA repair damage indicators.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/anticancer-potency-of-egyptian-venom-snakes-on-mcf-7-and-hepg2-carcinoma-cells/336248/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/anticancer-potency-of-egyptian-venom-snakes-on-mcf-7-and-hepg2-carcinoma-cells/336248.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-22","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which cell lines were used to test the anticancer activity of Egyptian snake venoms?","Question",{"text":63,"@type":64},"The study used breast cancer cells (MCF-7) and hepatocarcinoma cells (HepG2) in an in vitro assay.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did venom potency differ between MCF-7 and HepG2 cells?",{"text":68,"@type":64},"The venoms were more potent on MCF-7 than on HepG2, with inhibition percentages reaching 71.47–99.02% for MCF-7, while HepG2 IC50 values ranged from 4.32 up to 217.90 µg/ml.",{"name":70,"@type":61,"acceptedAnswer":71},"What biomarkers and assays were used to investigate venom effects on the cells?",{"text":72,"@type":64},"Biomarkers were measured to assess apoptotic-related effects, including LDH activity and changes in glutathione (GSH) and malondialdehyde (MDA), along with indicators of DNA repair/damage. The study also references MTT-based cell viability testing.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336248,1790107999,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d",8,"Original Article  \nAnticancer potency of Egyptian venom snakes on MCF-7 and HepG2 carcinoma cells  \nSherif Abdallah 1, Khaled Y. Abdel-Halim 2 ,* and Abeer Alm-Eldeen 1  \n1 Department of Zoology, Faculty of Science, Tanta University, Tanta, Egypt  \n2 Mammalian & Aquatic Toxicology Department, Central Agricultural Pesticides Laboratory (CAPL), Agricultural Research Center (ARC), Giza, Egypt  \n[Correspondence:](Correspondence: khaled_yassen68@yahoo.com)[ ](Correspondence: khaled_yassen68@yahoo.com)[khaled_yassen68@yahoo.com](Correspondence: khaled_yassen68@yahoo.com)  \nReceived: September 11, 2023 Accepted: December 13, 2023 Recommended by: Dr. Woo-Keun Kim  \nAbstract  \nBreast and hepatic cancers are the leading incidences in the globe occurring of the human sufferings from various cancers. Snake venoms have been reported to provide effective therapeutic agents. The current study investigates the anticancer potency of Egyptian venoms snakes on two cells: breast cancer cells (MCF-7) and hepato-cancer cells (HepG2)(In vitro assay). The examined venoms were more potent on MCF-7 than HepG2 cells. Their inhibition % on MCF-7 ranged from 71.47 to 99.02% with medium inhibition concentrations (IC50s): 3.48, 3.60, 3.70, 4.33, and 4.49 µ g/ml for venoms: Echis pyramid (E.H), Cerastes vipera (C.V), Naja haje (N.H), Echis coloratus (E.C), and Cerastes cerastes (C.C), respectively. The values of IC50s on HepG2 were 4.32, 17.77, 59.72, 63.75, and 217.90 µ g/ml for toxins: E.C, E.P, C.V, C.C, and N.H, respectively. Some biomarkers were conducted to investigate the apoptotic effects of toxins into the cells. Increasing profiles of lactate dehydrogenase (LDH) activity and levels of glutathione content (GSH) and malodialdhyde (MDA) as well as repairment of DNA indicated such these actions. So, more reliable investigations on these venoms were needed to provide intelligent therapeutic agent for cancer treatment.  \nKeywords: Egyptian venom snakes, Anticancer effects, MTT test, Biomarkers  \nIntroduction  \nIn fact, nature contains a huge diversity of bioactive molecules which have therapeutic activity. Utilization of natural anticancer agents has great potential to overcome cancer and yield promising results [1] . Venomous animals play a vital role in the discovery of novel therapeutic candidates. They provide various venoms to prevent themselves from external surroundings [2]. The venom gland of snakes has been the subject of numerous studies due to the highly anticancer action of their secretions and the evolutionary significance of this specialized trophic and defensive adaptation. Scientists over the past few decades have postulated that despite of the harmful and life-threatening effects of snake venom, its component may provide highly specific research tools for the development of novel life-saving medicines and drugs against some common and life-threatening diseases. Egypt is a rich source of flora and fauna is also home to a rich diversity of snake's species. However, few studies are reported about the venom gland from Egypt [3-6] . Shanbhag et al. (2015) [7] explored the potential of snake venoms in treating cancer. They noted that snake venoms have been used as traditional medicine for centuries and their components have a high specificity and efficacy in targeting cells and their components. Furthermore, snake venoms exhibit greater cytotoxicity towards tumor cells compared to normal cells, and have several therapeutic actions that make them an attractive option for cancer treatment. Recent advancements in technology have enabled the identification and extraction of new therapeutic components from snake venoms in a shorter time frame.  \nThe venoms from various snakes are important agents for the treatment of several types of cancers. As stated previously in the literature cites, several toxins from snake venom have shown promise as potential candidates for future ovarian cancer treatments [8], hepatocellular carcinoma (HCC) [9, 10], colore","cbCaivA3LhrPSnkP","https://ap.wps.com/l/cbCaivA3LhrPSnkP","pdf",1375138,15,"English","# Abstract\n# Keywords\n# Introduction\n# Materials and Methods","[{\"question\":\"Which cell lines were used to test the anticancer activity of Egyptian snake venoms?\",\"answer\":\"The study used breast cancer cells (MCF-7) and hepatocarcinoma cells (HepG2) in an in vitro assay.\"},{\"question\":\"How did venom potency differ between MCF-7 and HepG2 cells?\",\"answer\":\"The venoms were more potent on MCF-7 than on HepG2, with inhibition percentages reaching 71.47–99.02% for MCF-7, while HepG2 IC50 values ranged from 4.32 up to 217.90 µg/ml.\"},{\"question\":\"What biomarkers and assays were used to investigate venom effects on the cells?\",\"answer\":\"Biomarkers were measured to assess apoptotic-related effects, including LDH activity and changes in glutathione (GSH) and malondialdehyde (MDA), along with indicators of DNA repair/damage. The study also references MTT-based cell viability testing.\"}]","Anticancer potency of Egyptian venom snakes on MCF-7 and HepG2 carcinoma cells | PDF",1790014241,38,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88db6a9351ad455458677bf2ff1fd3b3.webp",983,1390,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2f553c6e709979b90feb897591857ab.webp",982,1388,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74cbb5796f3aadd19ff1e748d28b0dbb.webp",981,1387,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffce0e0fae9ef79d8612813a80697726.webp",980,1385,{"code":4,"msg":82,"data":117},[118,122,126,130,135,139,144,147,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":131,"slug":162},19,"General","general"]